BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 729059)

  • 1. [Somatomedin following administration of growth hormone in pituitary dwarfism].
    Marek J; Kopecký A; Schüllerová M; Schreiberová O
    Cesk Pediatr; 1978 Oct; 33(10):582-6. PubMed ID: 729059
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioimmunoassayable serum somatomedin B in normal subjects and in patients with acromegaly and pituitary dwarfism: effects of human growth hormone therapy.
    Wajchenberg BL; Liberman B; Gomes EN; Pieroni RR
    Horm Metab Res; 1980 Oct; 12(10):516-9. PubMed ID: 7439876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior of the somatotropic hormone and of somatomedin (sulfation factor) in achondroplasia].
    Isidori A; Cianfriglia F; Dondero F
    Folia Endocrinol; 1974 Apr; 27(2):179-84. PubMed ID: 4406489
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum levels of somatomedin A and growth during long-term treatment of patients with pituitary dwarfism with human growth hormone.
    Takano K; Hizuka N; Shizume K; Hasumi Y
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):385-97. PubMed ID: 229685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers.
    Valenta LJ; Sigel MB; Lesniak MA; Elias AN; Lewis UJ; Friesen HG; Kershnar AK
    N Engl J Med; 1985 Jan; 312(4):214-7. PubMed ID: 3965948
    [No Abstract]   [Full Text] [Related]  

  • 6. [Severe dwarfism with high plasma hGH levels and no somatomedin acitvity: Laron's syndrome (author's transl)].
    Mariani P; Gourmelen M; Carnot JF; Saignes F; Cayroche P
    Sem Hop; 1980 Nov 18-25; 56(43-44):1853-6. PubMed ID: 6256891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate.
    Rosenfeld RG; Kemp SF; Hintz RL
    J Clin Endocrinol Metab; 1981 Sep; 53(3):611-7. PubMed ID: 7021582
    [No Abstract]   [Full Text] [Related]  

  • 8. Acquired refractoriness to growth hormone in a patient with isolated growth hormone deficiency: growth and plasma somatomedin-C response to high-dose growth hormone therapy.
    Winterer J; Chrousos G; Cassorla F; Loriaux DL
    J Pediatr; 1984 Jun; 104(6):908-11. PubMed ID: 6539376
    [No Abstract]   [Full Text] [Related]  

  • 9. [Activity of blood somatomedin during childhood in normal subjects and in delayed growth].
    Pierson M; Grignon G; Malaprade D; Hartemann P
    Ann Biol Clin (Paris); 1976; 34(1):11-8. PubMed ID: 970694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transferrin, somatomedins and growth].
    Donnadieu M; Schimpff RM; Garnier P; Martinez MJ; Chaussain JL; Job JC
    C R Seances Soc Biol Fil; 1980; 174(4):564-73. PubMed ID: 6449240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Growth disorders in childhood].
    Bierich JR
    Fortschr Med; 1972 Sep; 90(27):961-6. PubMed ID: 4653170
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of hGH treatment on somatomedin levels in the serum (as determined by 35-S uptake into cartilage).
    Schimpff RM; Donnadieu M; Gourmelen M; Girard F
    Horm Metab Res; 1974 Nov; 6(6):494-8. PubMed ID: 4476721
    [No Abstract]   [Full Text] [Related]  

  • 13. Human somatomedin. Determination, occurrence, biological activity and purification.
    Hall K
    Acta Endocrinol Suppl (Copenh); 1972; 163():1052. PubMed ID: 4538721
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormal growth hormone and dwarfism.
    Abucham-Filho JZ; Czepielewski MA; Ribeiro SR; Jaber HE; Lengyel AM; Chacra AR; Vieira JG
    N Engl J Med; 1985 Jul; 313(4):268-9. PubMed ID: 4040212
    [No Abstract]   [Full Text] [Related]  

  • 15. [The serum level of sulfatation factor (somatomedine) in growth retardations, cerebral gigantism and acromegaly].
    Lecornu M
    Arch Fr Pediatr; 1973; 30(6):595-608. PubMed ID: 4375947
    [No Abstract]   [Full Text] [Related]  

  • 16. [Somatomedin activity of the serum in the normal child and in hypopituitarism].
    Binet E; Schlumberger A; Chaussain JL; Job JC
    Arch Fr Pediatr; 1974 Apr; 31(4):339-46. PubMed ID: 4368260
    [No Abstract]   [Full Text] [Related]  

  • 17. [Somatomedins and growth disorders].
    Job JC; Donnadieu M; Schimpff RM
    Rev Prat; 1979 Feb; 29(11):925-6, 929-30, 933-4. PubMed ID: 432489
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of growth hormone in pediatrics in pituitary dwarfism].
    Verron G
    Z Gesamte Inn Med; 1968 Aug; 23(16):Suppl:252-4. PubMed ID: 5727624
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of pituitary dwarfism using small doses of human growth hormone].
    Schröder KE; Schleyer M; Homoki J; Teller W; Pfeiffer EF
    Dtsch Med Wochenschr; 1972 Dec; 97(48):1849-53. PubMed ID: 4629115
    [No Abstract]   [Full Text] [Related]  

  • 20. [Our experience with the management of pituitary dwarfism].
    Hníková O; Kracmar P; Subrt I
    Cesk Pediatr; 1978 Oct; 33(10):591-3. PubMed ID: 729061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.